Daniel Hassan
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Microbiology top 10%
- Antimicrobial Peptides and Activities
Papers in
-
- Lipid Membrane Structure and Behavior 3
- RNA Interference and Gene Delivery 2
- Biochemical and Structural Characterization 1
-
- Advanced Drug Delivery Systems 3
- Co-authors
- Thirumala Govender (6 shared papers)Calvin A. Omolo (5 shared papers)Chunderika Mocktar (4 shared papers)Hibah M. Aldawsari (1 shared paper)Rahul Shukla (1 shared paper)Sima Singh (1 shared paper)Prashant Kesharwani (1 shared paper)Nagashekhara Molugulu (1 shared paper)
- Journals
- Molecular Pharmaceutics (1 paper)International Journal of Biological Macromolecules (1 paper)International Journal of Pharmaceutics (1 paper)Colloids and Surfaces B Biointerfaces (1 paper)Drug Discovery Today (1 paper)
- Partner nations
- South AfricaUnited StatesKenya
In The Last Decade
Daniel Hassan
8 papers receiving 339 citations
Peers
Comparison fields: 5 of 71
- Pharmaceutical Science 67
- Microbiology 51
- Biomaterials 70
- Molecular Medicine 18
- Oncology 69
Countries citing papers authored by Daniel Hassan
This map shows the geographic impact of Daniel Hassan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hassan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hassan more than expected).
Fields of papers citing papers by Daniel Hassan
This network shows the impact of papers produced by Daniel Hassan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hassan. The network helps show where Daniel Hassan may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Hassan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 119 | |
| 2 | 2019 | 59 | |
| 3 | 2020 | 58 | |
| 4 | 2019 | 37 | |
| 5 | 2020 | 28 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 14 | |
| 8 | 2022 | 12 | |
| 9 | 2023 | 0 |
About Daniel Hassan
Daniel Hassan is a scholar working on Molecular Biology, Pharmaceutical Science, Microbiology, Infectious Diseases and Organic Chemistry, having authored 9 papers that have together received 343 indexed citations. Recurring topics across this work include Lipid Membrane Structure and Behavior (3 papers), Advanced Drug Delivery Systems (3 papers), RNA Interference and Gene Delivery (2 papers), Antimicrobial Peptides and Activities (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), MicroRNA in disease regulation (1 paper), Antimicrobial Resistance in Staphylococcus (1 paper) and Biochemical and Structural Characterization (1 paper). The work is most often cited by research in Pharmaceutical Science (67 citations), Microbiology (51 citations), Biomaterials (70 citations), Molecular Medicine (18 citations) and Oncology (69 citations). Daniel Hassan has collaborated with scholars based in South Africa, United States and Kenya. Frequent co-authors include Thirumala Govender, Calvin A. Omolo, Chunderika Mocktar, Hibah M. Aldawsari, Rahul Shukla, Sima Singh, Prashant Kesharwani, Nagashekhara Molugulu, Victoria Oluwaseun Fasiku and Nikhil Agrawal. Their work appears in journals such as Molecular Pharmaceutics, International Journal of Biological Macromolecules, International Journal of Pharmaceutics, Colloids and Surfaces B Biointerfaces and Drug Discovery Today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.